| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Activating transcription factor 4 in erythroid development and β-thalassemia: a powerful regulator with therapeutic potential
|
Li, Jingmin
|
|
|
103 |
8 |
p. 2659-2670
|
artikel
|
| 2 |
A HNRNPC::RARB variant of acute promyelocytic leukemia with concurrent myeloid sarcoma of the spine
|
Li, Ting
|
|
|
103 |
8 |
p. 3255-3256
|
artikel
|
| 3 |
Alliance between titans: combination strategies of CAR-T cell therapy and oncolytic virus for the treatment of hematological malignancies
|
Gao, Xuejin
|
|
|
103 |
8 |
p. 2569-2589
|
artikel
|
| 4 |
Analysis of mutation profiles in extranodal NK/T-cell lymphoma: clinical and prognostic correlations
|
Chang, Yu-Cheng
|
|
|
103 |
8 |
p. 2917-2930
|
artikel
|
| 5 |
A preliminary study of roxadustat in the treatment of aplastic anemia patients with inadequate erythroid responses
|
Shi, Yimeng
|
|
|
103 |
8 |
p. 2757-2763
|
artikel
|
| 6 |
A promising natural product in diffuse large B-cell lymphoma therapy by targeting PIM1
|
Zhang, Xinyun
|
|
|
103 |
8 |
p. 2905-2915
|
artikel
|
| 7 |
APTT critical value establishment in four different reagent/instrument systems based on single factor deficiencies
|
Huang, Hualan
|
|
|
103 |
8 |
p. 3219-3227
|
artikel
|
| 8 |
A real-world pharmacovigilance study investigating the toxicities of histone deacetylase inhibitors
|
Li, Wenjie
|
|
|
103 |
8 |
p. 3207-3217
|
artikel
|
| 9 |
A retrospective observational study of ibrutinib in chronic lymphocytic leukaemia in a real-life setting in France using the national claims database (OSIRIS)
|
Choquet, Sylvain
|
|
|
103 |
8 |
p. 2969-2981
|
artikel
|
| 10 |
Association of routine hematological parameters with the development of monoclonal gammopathies: a case-control study of 134,740 patients
|
Røllum-Larsen, Jakob
|
|
|
103 |
8 |
p. 3005-3013
|
artikel
|
| 11 |
Challenges in chimeric antigen receptor-T cell product administration in a high tumor-burden elderly patient with mantle-cell lymphoma
|
Pizzano, Umberto
|
|
|
103 |
8 |
p. 3261-3262
|
artikel
|
| 12 |
Chemotherapy vs. “TKI + immunotherapy” in treatment of B-cell acute lymphoblastic leukemia harboring the RCSD1::ABL2 fusion gene
|
Li, Yan
|
|
|
103 |
8 |
p. 3257-3259
|
artikel
|
| 13 |
Chidamide combined with a modified Bu-Cy conditioning regimen improves survival in patients with T-cell acute lymphoblastic leukemia/lymphoma undergoing allogeneic hematopoietic stem cell transplantation
|
Cao, Xuanqi
|
|
|
103 |
8 |
p. 3083-3093
|
artikel
|
| 14 |
Clinicopathological analysis of immunohistochemical CD47 and signal-regulatory protein-α expression in Extranodal Natural killer/T-cell lymphoma
|
Tan, Zaixiang
|
|
|
103 |
8 |
p. 3033-3042
|
artikel
|
| 15 |
Comorbidities and survival of multiple myeloma patients diagnosed in Finland between 2000 and 2021
|
Kysenius, Kai
|
|
|
103 |
8 |
p. 2931-2943
|
artikel
|
| 16 |
Comprehensive procedure for injecting Evusheld® for hematological diseases in a single institute
|
Imataki, Osamu
|
|
|
103 |
8 |
p. 3193-3198
|
artikel
|
| 17 |
Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations
|
Wang, Xue-zhu
|
|
|
103 |
8 |
p. 3229-3233
|
artikel
|
| 18 |
Correction to: Clinical prognostic value of different NPM1 mutations in acute myeloid leukemia patients
|
Shi, Yu
|
|
|
103 |
8 |
p. 3281
|
artikel
|
| 19 |
Correction to: Spanish registry of hemoglobinopathies and rare anemias (REHem- AR): demographics, complications, and management of patients with β-thalassemia
|
Bardón-Cancho, Eduardo J.
|
|
|
103 |
8 |
p. 3283-3284
|
artikel
|
| 20 |
COVID-19 severity in patients with chronic lymphocytic leukemia treated with venetoclax: a single-center observational cohort study
|
Thau, Sophie
|
|
|
103 |
8 |
p. 3053-3060
|
artikel
|
| 21 |
Current status and future prospects of activated recombinant coagulation factor VIIa, NovoSeven®, in the treatment of haemophilia and rare bleeding disorders
|
Shima, Midori
|
|
|
103 |
8 |
p. 2647-2658
|
artikel
|
| 22 |
Cytogenetic and epidemiological profile of chronic myeloid leukemia in Morocco
|
Benchikh, Sara
|
|
|
103 |
8 |
p. 2765-2774
|
artikel
|
| 23 |
Daratumumab and venetoclax combined with CAGE for late R/R T-ALL/LBL patients: Single-arm, open-label, phase I study
|
Shi, Hui
|
|
|
103 |
8 |
p. 2993-3004
|
artikel
|
| 24 |
Development and validation of an early mortality risk model for pediatric hemophagocytic lymphohistiocytosis: a comparison with HScore, PELOD-2, P-MODS, and pSOFA
|
Tang, Zhexuan
|
|
|
103 |
8 |
p. 2699-2709
|
artikel
|
| 25 |
Development of disseminated intravascular coagulation in asymptomatic leukemic non-nodal mantle cell lymphoma
|
Kondo, Takumi
|
|
|
103 |
8 |
p. 3273-3275
|
artikel
|
| 26 |
Donor’s age influences outcome in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide - a single center experience
|
Zielińska, Patrycja
|
|
|
103 |
8 |
p. 3095-3104
|
artikel
|
| 27 |
Do NPM1 and FLT3-ITD mutations modify prognosis in patients treated with non-intensive regimens?
|
Suárez, E. U.
|
|
|
103 |
8 |
p. 2845-2851
|
artikel
|
| 28 |
Dry gangrene in a patient with sickle cell disease on hydroxyurea: a case report
|
Bhangu, Gurjeet
|
|
|
103 |
8 |
p. 3277-3279
|
artikel
|
| 29 |
Effective management of heparin-resistant thrombosis: a case study on rivaroxaban therapy guided by thromboelastography
|
Hou, Chuandong
|
|
|
103 |
8 |
p. 3267-3268
|
artikel
|
| 30 |
Efficacy of chidamide maintenance therapy versus autologous stem cell transplantation versus observation as a post-remission choice in the survival of adult patients with peripheral T-cell lymphoma: Post hoc analysis of a prospective, multicenter, phase 2 study in China
|
Wang, Wei
|
|
|
103 |
8 |
p. 3061-3069
|
artikel
|
| 31 |
Exploring and clinical validation of prognostic significance and therapeutic implications of copper homeostasis-related gene dysregulation in acute myeloid leukemia
|
Abulimiti, Maierbiya
|
|
|
103 |
8 |
p. 2797-2826
|
artikel
|
| 32 |
FRACTION: protocol of a phase II study of Fedratinib and Nivolumab combination in patients with myelofibrosis and resistance or suboptimal response to JAK-inhibitor treatment of the German MPN study group (GSG-MPN)
|
Isfort, Susanne
|
|
|
103 |
8 |
p. 2775-2785
|
artikel
|
| 33 |
Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)
|
Marco Sánchez, José Manuel
|
|
|
103 |
8 |
p. 2743-2755
|
artikel
|
| 34 |
Hematocrit control and thrombotic risk in patients with polycythemia vera treated with ruxolitinib in clinical practice
|
Chojecki, Aleksander
|
|
|
103 |
8 |
p. 2837-2843
|
artikel
|
| 35 |
Impact of additional cytogenetic aberrations at diagnosis on prognosis of adults patients with Philadelphia chromosome positive acute lymphoblastic leukemia undergoing allogeneic hematopoietic cell transplantation: a retrospective analysis
|
Zheng, Jing
|
|
|
103 |
8 |
p. 2983-2991
|
artikel
|
| 36 |
Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience
|
Danesin, Nicolò
|
|
|
103 |
8 |
p. 2961-2968
|
artikel
|
| 37 |
Inflammation mediated angiogenesis in chronic lymphocytic leukemia
|
Mitrović-Ajtić, Olivera
|
|
|
103 |
8 |
p. 2865-2875
|
artikel
|
| 38 |
Latent tuberculosis infection detected by quantiferon-TB assay in patients with multiple myeloma receiving novel drugs: focus on reactivation prophylaxis in a retrospective, single-center study
|
Sgherza, Nicola
|
|
|
103 |
8 |
p. 3251-3253
|
artikel
|
| 39 |
Loss of NLRP6 expression increases the severity of intestinal injury after syngeneic hematopoietic stem cell transplantation
|
Zhu, Shengyun
|
|
|
103 |
8 |
p. 3145-3154
|
artikel
|
| 40 |
Low NDRG2, regulated by the MYC/MIZ-1 complex and methylation, predicts poor outcomes in DLBCL patients
|
Wu, Shuang
|
|
|
103 |
8 |
p. 2877-2892
|
artikel
|
| 41 |
Monocyte-to-platelets ratio (MPR) at diagnosis is associated with inferior progression-free survival in patients with mantle cell lymphoma: a multi-center real-life survey
|
Duminuco, Andrea
|
|
|
103 |
8 |
p. 3043-3052
|
artikel
|
| 42 |
Myeloproliferative neoplasm with eosinophilia and coexisting BCR::ABL1 and PDGFRB rearrangement: favorable and rapid response to imatinib
|
Yao, Sun
|
|
|
103 |
8 |
p. 3247-3250
|
artikel
|
| 43 |
N6-methyladenosine RNA modifications: a potential therapeutic target for AML
|
Hu, Rong
|
|
|
103 |
8 |
p. 2601-2612
|
artikel
|
| 44 |
Pathophysiology and management of iron deficiency anaemia in pregnancy: a review
|
Kirthan, J. P. Akshay
|
|
|
103 |
8 |
p. 2637-2646
|
artikel
|
| 45 |
Plasmapheresis effectively abrogates severe liver toxicity of pegaspargase in a patient with acute lymphoblastic leukemia
|
Tölle, Markus
|
|
|
103 |
8 |
p. 3269-3271
|
artikel
|
| 46 |
Post-transplant lymphoproliferative disease of two different histological types
|
Onaka, Takashi
|
|
|
103 |
8 |
p. 3263-3265
|
artikel
|
| 47 |
Prophylactic therapy using epigenetic agents for RUNX1::RUNXT1-positive high-risk AML after Allo-HSCT
|
Guo, Wenwen
|
|
|
103 |
8 |
p. 3155-3163
|
artikel
|
| 48 |
Psychological and physical side effects during G-CSF mobilization in related donors of allo-HCT
|
Cai, Lingxia
|
|
|
103 |
8 |
p. 3199-3206
|
artikel
|
| 49 |
Quality of life assessment in diffuse large B-cell lymphoma (DLBCL) in REFLECT: a prospective, non-interventional, multicenter, German study, assessing Sandoz rituximab in combination with CHOP
|
Kubuschok, Boris
|
|
|
103 |
8 |
p. 3165-3178
|
artikel
|
| 50 |
Red cell distribution width and prognosis in myelofibrosis patients treated with ruxolitinib
|
Cattaneo, Daniele
|
|
|
103 |
8 |
p. 2787-2795
|
artikel
|
| 51 |
Reduced intensity conditioning regimen of fludarabine, busulfan, ATG based haploidentical stem cell transplantation for older or unfit patients
|
Pan, Mingyue
|
|
|
103 |
8 |
p. 3105-3119
|
artikel
|
| 52 |
Reduced-toxicity conditioning regimen with low dose post-transplantation cyclophosphamide and low-dose anti-thymocyte globulin as graft-versus-host disease prophylaxis for haploidentical stem cell transplantation in older patients
|
Ye, Peipei
|
|
|
103 |
8 |
p. 3135-3143
|
artikel
|
| 53 |
Refractory pure red cell aplasia associated with T-cell large granular lymphocyte leukemia treated by ruxolitinib
|
Gong, Yuemin
|
|
|
103 |
8 |
p. 3239-3242
|
artikel
|
| 54 |
Reporting of adverse events of treatment interventions in multiple myeloma: an overview of systematic reviews
|
Mainou, Maria
|
|
|
103 |
8 |
p. 2681-2697
|
artikel
|
| 55 |
Research progress of additional pathogenic mutations in chronic neutrophilic leukemia
|
Gao, Jiapei
|
|
|
103 |
8 |
p. 2591-2600
|
artikel
|
| 56 |
Risk factors for Non-Hodgkin’s lymphoma in autoimmune disease: a large database analysis
|
Chennapragada, Suma Sri
|
|
|
103 |
8 |
p. 3029-3031
|
artikel
|
| 57 |
Risk factors of early disease progression and decreased survival for multiple myeloma patients after upfront autologous stem cell transplantation
|
Hsu, Te-Lin
|
|
|
103 |
8 |
p. 2893-2904
|
artikel
|
| 58 |
Role and application of chemokine CXCL13 in central nervous system lymphoma
|
Li, Cuicui
|
|
|
103 |
8 |
p. 2671-2680
|
artikel
|
| 59 |
Ruxolitinib for the treatment of acute graft-versus-host disease: a retrospective analysis
|
Denk, Alexander
|
|
|
103 |
8 |
p. 3071-3081
|
artikel
|
| 60 |
Sickle cell disease: combination new therapies vs. CRISPR-Cas9 potential and challenges — review article
|
Youssry, Ilham
|
|
|
103 |
8 |
p. 2613-2619
|
artikel
|
| 61 |
Significance of absolute neutrophil count before allogeneic hematopoietic stem cell transplantation in adult patients with aplastic anemia
|
Nakamura, Yukinori
|
|
|
103 |
8 |
p. 3121-3133
|
artikel
|
| 62 |
Silencing of the DNA damage repair regulator PPP1R15A sensitizes acute myeloid leukemia cells to chemotherapy
|
Bouchla, Anthi
|
|
|
103 |
8 |
p. 2853-2863
|
artikel
|
| 63 |
Specificity protein 1/3 regulate T-cell acute lymphoblastic leukemia cell proliferation and apoptosis through β-catenin by acting as targets of miR-495-3p
|
Zheng, Boyang
|
|
|
103 |
8 |
p. 2945-2960
|
artikel
|
| 64 |
Stable responses to danicopan as add-on to ravulizumab in two patients with paroxysmal nocturnal hemoglobinuria
|
Füreder, Wolfgang
|
|
|
103 |
8 |
p. 3235-3238
|
artikel
|
| 65 |
STK10 mutations block erythropoiesis in acquired pure red cell aplasia via impairing ribosome biogenesis
|
Yang, Jichun
|
|
|
103 |
8 |
p. 2711-2720
|
artikel
|
| 66 |
Targeting histone deacetylase 1 (HDAC1) in the bone marrow stromal cells revers imatinib resistance by modulating IL-6 in Ph + acute lymphoblastic leukemia
|
Wei, Danna
|
|
|
103 |
8 |
p. 3015-3027
|
artikel
|
| 67 |
The gut microbiome: an important factor influencing therapy for pediatric acute lymphoblastic leukemia
|
Xu, Yafang
|
|
|
103 |
8 |
p. 2621-2635
|
artikel
|
| 68 |
The long-term efficacy of eltrombopag in children with immune thrombocytopenia
|
Yang, Li-
|
|
|
103 |
8 |
p. 2721-2727
|
artikel
|
| 69 |
Thrombopoietin receptor agonists regulate myeloid-derived suppressor cell-mediated immunomodulatory effects in ITP
|
Zhu, Yingqiao
|
|
|
103 |
8 |
p. 2729-2741
|
artikel
|
| 70 |
Transcobalamin deficiency — a rare genetic defect in transportation of cobalamin; case report
|
Iqbal, Neelofar
|
|
|
103 |
8 |
p. 3243-3246
|
artikel
|
| 71 |
Venetoclax adverse event monitoring: a safety meta-analysis of randomized controlled trials and a retrospective evaluation of the FAERS
|
KT, Muhammed Favas
|
|
|
103 |
8 |
p. 3179-3191
|
artikel
|
| 72 |
WT1 gene mutations impact post-transplant relapse in myelodysplastic syndrome with excess blasts 2 patients
|
Guo, Wenwen
|
|
|
103 |
8 |
p. 2827-2836
|
artikel
|
Tijdschrift beschrijving